Sebia reagents and services

The Florida Department of Health's Bureau of Public Health Laboratories, Newborn Screening Unit, seeks to purchase reagents, controls, calibrators, consumables, and related services specifically for the FDA-approved CAPILLARS 3 DBS automated analyzer. This equipment is essential for the qualitative screening of normal and abnormal hemoglobin from dry blood spots collected from newborns, enabling rapid and accurate detection of genetic and inheritable disorders at an early stage. The timely and precise results obtained through this screening process support immediate clinical interventions, thereby enhancing newborn healthcare outcomes. In accordance with applicable Florida regulations, the Department intends to make this procurement as a single source purchase from Sebia Inc., the sole provider of these specified reagents and services. The solicitation, identified by the number EXP2670, was posted on May 13, 2026, with responses due by June 3, 2026. The procurement falls under the NAICS code 41116105 and will be conducted within the state of Florida. The primary contact for this solicitation is Yasemin Sulker, who can be reached via email or phone for further inquiries.